Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972060priorityCriticalpatent/ECSP972060A/en
Publication of ECSP972060ApublicationCriticalpatent/ECSP972060A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Pyridine Compounds
(AREA)
Abstract
Las piridinas sustituídas por 2-arilo se obtienen al transformar piridilaldehídos con compuestos organometálicos y reducir selectivamente a continuación. Las piridinas sustituídas por 2-arilo son adecuadas como sustancia activa en medicamentos, especialmente en medicamentos para el tratamiento de la arterioesclerosis.2-Aryl-substituted pyridines are obtained by transforming pyridylaldehydes with organometallic compounds and selectively reducing thereafter. 2-Aryl-substituted pyridines are suitable as an active substance in medicines, especially in medicines for the treatment of arteriosclerosis.
ECSP9720601997-03-191997-03-19
PIRIDINES SUBSTITUTED FOR 2-ARYL (ILEA 31420-EC)
ECSP972060A
(en)
Methods of treating cell proliferative diseases, of treating a disorder associated with ksp kinesin activity, of ksp kinesin inhibition, of kps kinesin modulators and of screening compounds that bind ksp kinesin, and compounds
ANALOG COMPOUNDS OF (1R, CIS) -4- (6-AMINO-9H-PURIN-9-IL) -2-CYCLOPENTENE-1-METHANOL, PROCESS FOR PREPARATION, USE IN THE TREATMENT OF VIRAL INFECTIONS, AND PACKING THAT CONTAINS THEM
Compound, composition, methods for modulating ksp kinesin activity, for inhibiting ksp, for the treatment of a cell proliferative disease, and use of a compound